- Home
- CPRX vs BXMT Comparison
CPRX vs BXMT Comparison
Compare CPRX & BXMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CPRX | BXMT |
|---|---|---|
| Founded | 2002 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.4B |
| IPO Year | 2006 | N/A |
Fundamental Metrics
Financial Performance| Metric | CPRX | BXMT |
|---|---|---|
| Price | $24.48 | $19.27 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 4 |
| Target Price | ★ $33.25 | $20.33 |
| AVG Volume (30 Days) | 1.1M | ★ 1.3M |
| Earning Date | 02-25-2026 | 02-11-2026 |
| Dividend Yield | N/A | ★ 9.79% |
| EPS Growth | ★ 44.94 | N/A |
| EPS | ★ 1.71 | 0.62 |
| Revenue | ★ $578,196,000.00 | $393,335,000.00 |
| Revenue This Year | $19.87 | N/A |
| Revenue Next Year | $7.06 | $16.34 |
| P/E Ratio | ★ $14.31 | $30.86 |
| Revenue Growth | ★ 25.56 | N/A |
| 52 Week Low | $19.05 | $16.51 |
| 52 Week High | $26.58 | $21.24 |
Technical Indicators
Market Signals| Indicator | CPRX | BXMT |
|---|---|---|
| Relative Strength Index (RSI) | 62.29 | 46.74 |
| Support Level | $22.33 | $19.16 |
| Resistance Level | $23.31 | $19.62 |
| Average True Range (ATR) | 0.77 | 0.41 |
| MACD | 0.12 | -0.01 |
| Stochastic Oscillator | 95.47 | 54.19 |
Price Performance
Historical ComparisonAbout CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).
About BXMT Blackstone Mortgage Trust Inc.
Blackstone Mortgage Trust Inc is a real estate finance company involved in the origination and purchase of senior loans collateralized by commercial properties in North America, Europe, and Australia. The vast majority of the company's asset portfolio is comprised of floating rate loans secured by priority mortgages. These mortgages are mainly derived from office, hotel, and manufactured housing properties. A percentage of the collateralized real estate properties are located in New York, California, and the United Kingdom. Blackstone Mortgage Trust is managed by a subsidiary of The Blackstone Group and benefits from the market data provided by its parent company. Nearly all of Blackstone Mortgage Trust's revenue is generated in the form of interest income.